Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | International Journal of Neuropsychopharmacology | journal | 0.490 Q2 | 125 | 50 | 113 | 2485 | 150 | 110 | 1.34 | 49.70 |  |
| 52 | Journal of Applied Toxicology | journal | 0.459 Q2 | 103 | 124 | 235 | 3352 | 280 | 232 | 1.14 | 27.03 | |
| 53 | Immunopharmacology and Immunotoxicology | journal | 0.449 Q2 | 61 | 53 | 137 | 1624 | 170 | 137 | 1.18 | 30.64 | |
| 54 | International Antiviral News | journal | 0.448 Q2 | 8 | 25 | 84 | 313 | 62 | 54 | 1.00 | 12.52 | |
| 55 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.429 Q2 | 81 | 63 | 186 | 1888 | 245 | 169 | 1.39 | 29.97 | |
| 56 | Journal of Chemotherapy | journal | 0.428 Q2 | 56 | 150 | 295 | 4474 | 372 | 283 | 1.32 | 29.83 | |
| 57 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.423 Q2 | 67 | 70 | 187 | 1684 | 140 | 186 | 0.77 | 24.06 | |
| 58 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.416 Q2 | 57 | 43 | 110 | 1572 | 89 | 102 | 0.94 | 36.56 | |
| 59 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.414 Q2 | 92 | 52 | 112 | 1639 | 150 | 112 | 1.23 | 31.52 | |
| 60 | International Journal of Geriatric Psychopharmacology | journal | 0.411 Q1 | 11 | 0 | 75 | 0 | 102 | 71 | 0.41 | 0.00 | |
| 61 | Current Opinion in Molecular Therapeutics | journal | 0.405 Q2 | 67 | 82 | 183 | 3634 | 214 | 170 | 1.17 | 44.32 | |
| 62 | Expert Opinion on Therapeutic Patents | journal | 0.404 Q2 | 88 | 126 | 429 | 6674 | 437 | 424 | 1.02 | 52.97 | |
| 63 | Chemical Speciation and Bioavailability | journal | 0.400 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 64 | Journal of Liposome Research | journal | 0.390 Q2 | 64 | 28 | 107 | 1003 | 110 | 88 | 1.01 | 35.82 | |
| 65 | Phytotherapy Research | journal | 0.382 Q2 | 158 | 150 | 491 | 3332 | 358 | 489 | 0.79 | 22.21 | |
| 66 | Fundamental and Clinical Pharmacology | journal | 0.379 Q2 | 85 | 52 | 219 | 1599 | 260 | 215 | 1.08 | 30.75 | |
| 67 | Autonomic and Autacoid Pharmacology | journal | 0.376 Q2 | 24 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 68 | SAR and QSAR in Environmental Research | journal | 0.376 Q3 | 54 | 45 | 49 | 66 | 83 | 49 | 1.94 | 1.47 | |
| 69 | Clinical Toxicology | journal | 0.369 Q3 | 108 | 88 | 323 | 1775 | 460 | 249 | 1.64 | 20.17 | |
| 70 | ATLA Alternatives to Laboratory Animals | journal | 0.367 Q3 | 65 | 65 | 188 | 1402 | 177 | 163 | 0.78 | 21.57 | |
| 71 | Tumor Targeting | journal | 0.357 Q2 | 10 | 0 | 54 | 0 | 62 | 52 | 1.44 | 0.00 | |
| 72 | Drug Design and Discovery | journal | 0.350 Q3 | 20 | 1 | 66 | 0 | 55 | 62 | 0.83 | 0.00 | |
| 73 | Toxin Reviews | journal | 0.348 Q3 | 54 | 15 | 90 | 859 | 63 | 87 | 0.81 | 57.27 | |
| 74 | Toxicology in Vitro | journal | 0.332 Q3 | 125 | 96 | 245 | 2613 | 242 | 244 | 0.93 | 27.22 | |
| 75 | Advances in Antiviral Drug Design | book series | 0.330 Q2 | 12 | 0 | 7 | 0 | 7 | 5 | 1.00 | 0.00 | |
| 76 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.323 Q3 | 54 | 100 | 704 | 1831 | 368 | 702 | 0.51 | 18.31 | |
| 77 | International Journal of Cosmetic Science | journal | 0.314 Q2 | 77 | 42 | 116 | 838 | 82 | 113 | 0.67 | 19.95 | |
| 78 | Expert Opinion on Pharmacotherapy | journal | 0.301 Q3 | 93 | 168 | 105 | 11843 | 123 | 104 | 1.17 | 70.49 | |
| 79 | Biopharmaceutics and Drug Disposition | journal | 0.299 Q2 | 65 | 36 | 183 | 1661 | 147 | 181 | 0.86 | 46.14 | |
| 80 | Pharmaceutical Biology | journal | 0.297 Q2 | 88 | 97 | 232 | 2172 | 93 | 229 | 0.35 | 22.39 | |
| 81 | Acta Pharmacologica Sinica | journal | 0.294 Q3 | 117 | 207 | 589 | 3661 | 357 | 588 | 0.67 | 17.69 | |
| 82 | Drug Delivery | journal | 0.290 Q2 | 95 | 29 | 97 | 902 | 62 | 97 | 0.71 | 31.10 | |
| 83 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.275 Q3 | 25 | 21 | 54 | 738 | 52 | 28 | 0.93 | 35.14 | |
| 84 | ChemMedChem | journal | 0.273 Q2 | 119 | 157 | 351 | 2845 | 250 | 348 | 0.75 | 18.12 | |
| 85 | Journal of Pharmacy and Pharmacology | journal | 0.264 Q2 | 137 | 213 | 1792 | 6060 | 1028 | 1758 | 0.55 | 28.45 | |
| 86 | Reviews in Contemporary Pharmacotherapy | journal | 0.261 Q3 | 18 | 6 | 79 | 1445 | 107 | 79 | 2.28 | 240.83 | |
| 87 | Mathematical Medicine and Biology | journal | 0.260 Q3 | 49 | 19 | 64 | 472 | 38 | 64 | 0.41 | 24.84 | |
| 88 | Expert Opinion on Therapeutic Targets | journal | 0.254 Q3 | 106 | 47 | 135 | 5636 | 70 | 135 | 0.75 | 119.91 | |
| 89 | BioDrugs | journal | 0.237 Q3 | 79 | 70 | 230 | 4783 | 142 | 218 | 0.58 | 68.33 | |
| 90 | Expert Opinion on Emerging Drugs | journal | 0.233 Q3 | 54 | 23 | 70 | 2173 | 60 | 68 | 0.89 | 94.48 | |
| 91 | Pharmaceutical Journal | journal | 0.232 Q2 | 28 | 901 | 1036 | 1740 | 114 | 480 | 0.11 | 1.93 | |
| 92 | British Journal of Clinical Pharmacology, Supplement | journal | 0.231 Q2 | 33 | 18 | 12 | 649 | 25 | 11 | 0.00 | 36.06 | |
| 93 | Pharmacy and Pharmacology Communications | journal | 0.225 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 94 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 0.220 Q3 | 5 | 0 | 35 | 0 | 15 | 30 | 0.43 | 0.00 | |
| 95 | Current Opinion in Investigational Drugs | journal | 0.185 Q3 | 83 | 36 | 0 | 1888 | 0 | 0 | 0.00 | 52.44 | |
| 96 | Paediatric and Perinatal Drug Therapy | journal | 0.183 Q3 | 20 | 18 | 38 | 381 | 15 | 34 | 0.41 | 21.17 | |
| 97 | Pharmacology and Toxicology, Supplement | journal | 0.179 Q3 | 7 | 0 | 47 | 0 | 16 | 46 | 0.27 | 0.00 | |
| 98 | Comments on Toxicology | journal | 0.178 Q4 | 13 | 20 | 44 | 789 | 12 | 30 | 0.48 | 39.45 | |
| 99 | Toxicology Methods | journal | 0.178 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 100 | Toxic Substance Mechanisms | journal | 0.172 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data